International Consortium of Orthopaedic Registries (ICOR)

At a Glance
  • Status: Active Consortium
  • Year Launched: 2011
  • Initiating Organization: U.S. Food and Drug Administration
  • Initiator Type: Government
  • No disease focus
  • Location: International


The International Consortium of Orthopaedic Registries (ICOR) is a U.S. Food and Drug Administration (FDA)–sponsored initiative that is quickly evolving into a public-private partnership, with more than 30 registries participating worldwide. Its purpose is to facilitate and enhance inter-registry collaboration through the provision of a supportive infrastructure and the development of a distributed data network that uses innovative approaches to analyze the data. This approach is well suited to meet its goals of working with all registries, whether they are well-established or in the development stages. ICOR also aims to assist its participating organizations with a creation of a learning network. Most importantly registries maintain control of their own data, and, when they collaborate, they can contribute data in a manner that is not resource intensive.


ICOR’s mission is to facilitate international registry stakeholders’ collaboration and develop innovative methodological approaches for conducting robust analytic studies to fill the evidence gaps. The additional goal is to improve FDA’s understanding of safety and effectiveness of orthopedic devices.

In order to accomplish this mission, ICOR has begun work on three projects:

Consortium History

ICOR was launched in 2011 with an inaugural conference on May 9-10 at the FDA headquarters in Silver Spring, Md. This conference summarized the international data sources and methods for postmarket evaluations and surveillance of orthopedic devices. The conference attendees included 73 stakeholders from 29 orthopaedic joint registries (total joint arthroplasty) representing 14 nations. In addition, there were more than 25 nonregistry stakeholders representing industry, Agency for Health Care Research and Quality, National Institutes of Health, Centers for Medicare & Medicaid Services, academia, device regulatory agencies, and device cataloging experts insurers and payers. The meeting was the first main step to build the ICOR methodological infrastructure to evaluate orthopaedic implant safety and effectiveness.


Points of Contact

Art Sedrakyan

Liz Paxton

Lucas Romero

Rebecca Love

Sponsors & Partners

American Joint Replacement Registry

Australian Orthopaedic Association National Joint Replacement Registry

California Joint Replacement Registry

Canadian Joint Replacement Registry

Catalan Arthroplasty Register

Croatian Arthroplasty Register

Czech Republic National Register of Joint Replacements

Danish Hip Arthroplasty Register

Danish Knee Arthroplasty Register

Dutch Arthroplasty Register (NOV-LROI)

Finnish National Arthroplasty Register

FORCE-TJR Registry

German Arthroplasty Register

Harris Joint Registry at Massachusetts General Hospital

HealthEast Joint Replacement Registry

Hospital for Special Surgery

Kaiser Permanente National Implant Registries

Lithuanian Arthroplasty Register

Malawi National Arthroplasty Registry

Mayo Clinic Total Joint Registry

National Joint Registry for England and Wales

New England Baptist Hospital Registry

New Zealand National Joint Register

Norwegian Arthroplasty Register


Portuguese National Arthroplasty Register

Registro Ortopedico Lombardo Protesi (ROLP)

RIPO - Register of Orthopaedic Prosthetic Implants

Romanian Arthroplasty Register

Rush University Medical Center Joint Replacement Registry

Scottish Arthroplasty Project

Slovakian National Arthroplasty Register

Slovenian Arthroplasty Register

SoFCOT THA Registry

South African National Joint Registry

Swedish Hip Arthroplasty Register

Swedish Knee Arthroplasty Register

U.S. FDA Coordinating Center

U.S. FDA Coordinating Center and Kaiser Permanente Total Joint Replacement Registry

University of California, San Francisco

Virginia State Registry

Western Slope Study Group

Last Updated: 04/15/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.